11-47351241-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_000256.3(MYBPC3):c.290C>T(p.Ala97Val) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000000725 in 1,379,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000256.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.290C>T | p.Ala97Val | missense_variant, splice_region_variant | 2/35 | ENST00000545968.6 | NP_000247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.290C>T | p.Ala97Val | missense_variant, splice_region_variant | 2/35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.290C>T | p.Ala97Val | missense_variant, splice_region_variant | 2/34 | 5 | ENSP00000382193.2 | |||
MYBPC3 | ENST00000544791.1 | n.290C>T | splice_region_variant, non_coding_transcript_exon_variant | 2/27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.25e-7 AC: 1AN: 1379800Hom.: 0 Cov.: 37 AF XY: 0.00000148 AC XY: 1AN XY: 675624
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Dec 05, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 25, 2020 | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Ala97Val variant in MYBPC3 has been reported in 1 individual with hypertrophic cardiomyopathy (Walsh 2017 PMID: 27532257, LMM data) but was absent from large population studies. This variant is located in the last three bases of the exon, which is part of the 5' splice region. Computational tools predict a splicing impact through the creation of an alternate splice site which is in turn predicted to create a frameshift and premature termination and in vitro functional studies using a cell-based mini-gene splicing assay provide some evidence that this variant impacts splicing (Ito 2017 PMID: 28679633); however, these types of assays may not accurately represent biological function. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2, PP3, PS3_Supporting. - |
Hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 12, 2021 | This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with valine at codon 97 of the MYBPC3 protein (p.Ala97Val). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and valine. This variant has been reported in individual(s) affected with hypertrophic cardiomyopathy (PMID: 27532257). ClinVar contains an entry for this variant (Variation ID: 42670). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at